Cargando…

MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer

The migration and invasion inhibitory protein (MIIP) has been discovered recently to have inhibitory functions in cell proliferation and migration. Overexpression of MIIP reduced the intracellular steady-state level of epidermal growth factor receptor (EGFR) protein in lung cancer cells with no effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Jing, Fu, Jianhua, Ling, Yihong, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891030/ https://www.ncbi.nlm.nih.gov/pubmed/26824318 http://dx.doi.org/10.18632/oncotarget.7001

Ejemplares similares

MiIP: The Monomer Identification and Isolation Program
por: Bun, Christopher, et al.
Publicado: (2012)

MIIP is downregulated in gastric cancer and its forced expression inhibits proliferation and invasion of gastric cancer cells in vitro and in vivo
por: Sun, Dan, et al.
Publicado: (2018)

MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
por: Yan, Guang, et al.
Publicado: (2019)

MIIP is Downregulated in Gastric Cancer and Its Forced Expression Inhibits Proliferation and Invasion of Gastric Cancer Cells in vitro and in vivo [Corrigendum]
Publicado: (2021)

A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation
por: Wondrusch, C., et al.
Publicado: (2013)

MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
por: Wang, Yingmei, et al.
Publicado: (2016)

Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling
por: Yan, Guang, et al.
Publicado: (2019)

Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
por: Wang, Yingmei, et al.
Publicado: (2017)

MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis via negative modulation of the HIF-2α-CYR61 axis
por: Yan, Fengqi, et al.
Publicado: (2022)

Epidermal growth factor receptors in non-small cell lung cancer.
por: Veale, D., et al.
Publicado: (1987)

PKCε phosphorylates MIIP and promotes colorectal cancer metastasis through inhibition of RelA deacetylation
por: Chen, Tao, et al.
Publicado: (2017)

Magnetic Ion Imprinted Polymers (MIIPs) for Selective Extraction and Preconcentration of Sb(III) from Environmental Matrices
por: Jakavula, Silindokuhle, et al.
Publicado: (2021)

MIIP functions as a novel ligand for ITGB3 to inhibit angiogenesis and tumorigenesis of triple-negative breast cancer
por: Gao, Yujing, et al.
Publicado: (2022)

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
por: Sun, Si, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
por: Wee, Ping, et al.
Publicado: (2017)

Epidermal growth factor receptor and notch signaling in non‐small‐cell lung cancer
por: Pancewicz‐Wojtkiewicz, Joanna
Publicado: (2016)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
por: Palumbo, Giuliano, et al.
Publicado: (2020)

Inhibition of epidermal growth factor receptor attenuates LPS-induced inflammation and acute lung injury in rats
por: Shan, Xiaoou, et al.
Publicado: (2017)

Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
por: Li, Xiaoling, et al.
Publicado: (2020)

Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer
por: Liu, Tu-Chen, et al.
Publicado: (2016)

MicroRNA-128-b regulates epidermal growth factor receptor expression in non-small cell lung cancer
por: Li, Ling, et al.
Publicado: (2019)

Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement
por: Zhou, Jianya, et al.
Publicado: (2015)

The epidermal growth factor receptor (EGRF) in lung cancer
por: Carcereny, Enric, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Tumor evolution in epidermal growth factor receptor mutated non-small cell lung cancer
por: Velazquez, Ana I., et al.
Publicado: (2020)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
por: O’Leary, Connor, et al.
Publicado: (2020)

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
por: Harrison, Peter T., et al.
Publicado: (2020)

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer
por: Zhao, Wei, et al.
Publicado: (2022)

The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation
por: Liu, Tu-Chen, et al.
Publicado: (2016)

Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients
por: Li, Wen‐Qian, et al.
Publicado: (2021)

An extraction from Trametes robiniophila Murr. (Huaier) inhibits non-small cell lung cancer proliferation via targeting to epidermal growth factor receptor
por: Lv, Fei, et al.
Publicado: (2022)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Epidermal Growth Factor Receptor Mutation Status and the Impact on Clinical Outcomes in Patients with Non-Small Cell Lung Cancer
por: Huang, HM, et al.
Publicado: (2023)

An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer
por: Yoshimura, Akihiro, et al.
Publicado: (2018)

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
por: Bouchez, Clémentine, et al.
Publicado: (2020)

Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation
por: Ko, How-Wen, et al.
Publicado: (2022)

Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer: A case report
por: Li, Ding, et al.
Publicado: (2021)

Association of Epidermal Growth Factor Receptor Mutations with Metastatic Presentations in Non-Small Cell Lung Cancer
por: Na, Im Il, et al.
Publicado: (2011)

Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
por: Seyhan, Ekrem Cengiz, et al.
Publicado: (2010)

Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cells
por: Giannopoulou, Efstathia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_47e6nnoemba1iksfnlj076icsk